By end of 2023, 24 U.S. states plus DC had recreational sales, yet the health and usage data shows the picture is far from settled. Globally, legal cannabis is projected to reach $57.2 billion by 2026 with a 24.3% CAGR, while treatment outcomes, employment, taxes, and consumption trends keep moving in different directions. Let’s connect those dots across markets, regulators, and real-world use.
Key Takeaways
- In 2023, U.S. cannabis sales reached $28.9 billion, up 10.4% from 2022
- Colorado collected $423 million in cannabis taxes in 2023, funding schools and infrastructure
- California's legal cannabis market generated $5.3 billion in 2023 sales
- A clinical trial showed that cannabis with 10mg THC reduced chronic pain by 30% in 73% of patients vs placebo
- Epidiolex (CBD) reduced seizure frequency by 39% in Dravet syndrome patients in Phase 3 trials
- In a 2020 meta-analysis, medical cannabis reduced opioid use by 64% in chronic pain patients
- As of 2024, 24 U.S. states have legalized recreational cannabis, covering 54% of population
- Canada fully legalized recreational cannabis on October 17, 2018, under Cannabis Act
- Uruguay became first country to legalize recreational cannabis in 2013
- In 2022, approximately 52.5 million people aged 12 or older in the United States reported using cannabis in the past year, representing 18.7% of the population in that age group
- A 2023 study found that 22.0% of U.S. adults aged 18-25 used cannabis in the past month, the highest rate among age groups
- Globally, an estimated 219 million people used cannabis in 2022, making it the most widely used drug worldwide
- Heavy cannabis use associated with 2.1-fold increased risk of schizophrenia in men
- Daily cannabis use linked to 34% higher risk of heart attack per 2024 study
- Adolescent cannabis use increases depression risk by 37% in adulthood
In 2023 US cannabis sales hit $28.9 billion as legalization spread and usage reached new records.
Related reading
01 · Category
Economic Aspects30 stats
01
In 2023, U.S. cannabis sales reached $28.9 billion, up 10.4% from 2022
02
Colorado collected $423 million in cannabis taxes in 2023, funding schools and infrastructure
03
California's legal cannabis market generated $5.3 billion in 2023 sales
04
Global legal cannabis market projected to hit $57.2 billion by 2026, CAGR 24.3%
05
Canada’s legal cannabis sales were CAD 4.5 billion in 2023
06
U.S. cannabis industry employed 428,000 full-time workers in 2023
07
Illinois cannabis taxes yielded $1.5 billion since 2020 launch
08
Germany’s medical cannabis imports cost €1.2 billion in 2023
09
Michigan’s recreational cannabis sales hit $3.1 billion in 2023
10
Hemp-derived CBD market in U.S. valued at $5.3 billion in 2022
11
Nevada cannabis revenue topped $55 million monthly in 2023
12
Israel exported $500 million in medical cannabis products in 2023
13
Washington state cannabis taxes generated $466 million in 2023
14
U.S. ancillary cannabis businesses generated $2.5 billion in 2023
15
Oklahoma medical cannabis sales reached $1 billion in first year post-2018
16
Global cannabis beverage market expected to grow to $2.9 billion by 2028
17
Florida medical cannabis revenue was $1.8 billion in 2023
18
U.K. medical cannabis prescriptions rose 400% to 50,000 in 2023
19
Arizona recreational cannabis sales debuted with $30 million in first month 2021
20
In 2023, U.S. cannabis industry paid $3.5 billion in taxes
21
Oregon cannabis sales $1.7 billion since 2015
22
New Jersey first-year rec sales $700 million 2022
23
Global med cannabis market $14.9 billion in 2023
24
440,000 U.S. cannabis jobs projected by end 2023
25
New York rec sales $1.2 billion in first 2 years
26
Hemp fiber market $1.2 billion globally 2023
27
Connecticut cannabis taxes $250 million FY2023
28
Australia med cannabis $300 million AUD 2023
29
Virginia med sales $1 billion by 2023
30
Cannabis tourism generated $2 billion in Colorado 2023
Interpretation
Economic Aspects Interpretation
While politicians continue to debate its merits, cannabis is quietly and profitably funding schools, creating jobs, and building economies with all the sober efficiency of a Fortune 500 company.
02 · Category
Health Benefits28 stats
01
A clinical trial showed that cannabis with 10mg THC reduced chronic pain by 30% in 73% of patients vs placebo
02
Epidiolex (CBD) reduced seizure frequency by 39% in Dravet syndrome patients in Phase 3 trials
03
In a 2020 meta-analysis, medical cannabis reduced opioid use by 64% in chronic pain patients
04
Sativex (THC/CBD spray) improved spasticity scores by 20% in MS patients per 2019 review
05
Cannabis-based treatments alleviated chemotherapy-induced nausea in 70% of patients vs 10% placebo
06
A 2022 study found inhaled cannabis reduced PTSD symptoms by 50% in veterans over 8 weeks
07
CBD oil at 300mg daily reduced anxiety scores by 79% in 57 patients
08
Medical cannabis users reported 40% improvement in sleep quality in a 2021 Israeli study of 1,164 patients
09
In glaucoma patients, THC lowered intraocular pressure by 30-45% for 3-4 hours
10
Cannabis flower with 24% THC improved appetite by 75% in HIV/AIDS patients
11
A Phase 2 trial showed nabiximols reduced cancer pain by 1.37 points on NRS scale
12
In Crohn's disease, 10 patients achieved remission with inhaled cannabis vs 4 on placebo
13
Low-dose CBD (25mg) enhanced fear extinction in PTSD models by 65%
14
Medical cannabis reduced fibromyalgia pain by 2.5 points on VAS in 128 patients
15
THC:CBD 1:1 ratio improved bladder control in MS by 30%
16
In epilepsy, CBD adjunct therapy cut seizures by 50% in 43% of Lennox-Gastaut patients
17
Cannabis terpenes like myrcene enhanced anti-inflammatory effects by 40% in arthritis models
18
Vaping CBD reduced social anxiety by 60% in public speaking test
19
A randomized trial with 95 FM patients showed cannabis oil reduced pain by 1.7/10
20
In 128 cancer patients, MC improved sleep in 66% and appetite in 53%
21
THC/CBD oromucosal spray reduced MS spasticity by 0.8 points on 0-10 scale
22
In 30 HIV patients, dronabinol increased caloric intake by 600 kcal/day
23
CBD 600mg reduced anxiety in SAD patients during speech test
24
In 47 epilepsy patients, CBD reduced seizures by median 36.5%
25
Inhaled cannabis eased neuropathic pain by 3.3/10 reduction in 21 patients
26
MC registry data: 90% Parkinson's patients improved motor symptoms
27
Low-dose THC improved Alzheimer’s agitation in 9/10 patients
28
Cannabis reduced IBS symptoms in 50% of 19 patients over 8 weeks
Interpretation
Health Benefits Interpretation
While cannabis might still be fighting for its seat at the medical table, these statistics show it's not just pulling up a chair, but serving a full-course meal of symptom relief across a dozen debilitating conditions.
03 · Category
Legal and Policy29 stats
01
As of 2024, 24 U.S. states have legalized recreational cannabis, covering 54% of population
02
Canada fully legalized recreational cannabis on October 17, 2018, under Cannabis Act
03
Uruguay became first country to legalize recreational cannabis in 2013
04
Germany legalized recreational cannabis possession up to 25g in public from April 2024
05
U.S. federal law still classifies cannabis as Schedule I under Controlled Substances Act
06
Malta legalized recreational cannabis clubs in 2021, allowing up to 500 members per club
07
Thailand decriminalized cannabis in June 2022, leading to 8,000+ dispensaries
08
38 U.S. states allow medical cannabis as of 2024
09
Luxembourg legalized home cultivation of up to 4 plants per household in 2023
10
Mexico legalized recreational use up to 28g possession in June 2021
11
New Zealand rejected recreational legalization in 2020 referendum by 50.7%
12
Australia allows medical cannabis since 2016, but recreational illegal federally
13
U.K. rescheduled cannabis to Class B in 2009, medical access since 2018
14
Switzerland permits cannabis possession under 10g since 2013
15
Czech Republic allows home grow up to 5 plants since 2010
16
South Africa legalized private use and home grow up to 4 plants in 2018
17
U.S. DEA proposed rescheduling to Schedule III in May 2024
18
Brazil approved medical cannabis in 2015, first recreational bill in 2023
19
Netherlands tolerates sales up to 5g in coffeeshops since 1976
20
Spain medical cannabis bill passed 2022, coffeeshops tolerated
21
Georgia allows low-THC oil <5% since 2015
22
Jamaica decriminalized possession up to 2oz in 2015, Rastafari sacrament
23
Armenia legalized med cannabis 2023, first in region
24
Ohio legalized rec cannabis Issue 2 in Nov 2023
25
Kentucky med cannabis effective 2025 after 2023 law
26
Missouri legalized rec 2022, sales started Feb 2023
27
Philippines med cannabis pilot 2023 for 23 conditions
28
Colombia legalized med 2016, rec decrim 2023 SC ruling
29
Portugal decriminalized all drugs 2001, cannabis possession <25g admin offense
Interpretation
Legal and Policy Interpretation
While the world increasingly embraces cannabis with a confusing patchwork of laws, the U.S. federal government stubbornly clings to its outdated Schedule I status, making the nation's stance look like a half-legalized, bureaucratic schizophrenic trying to give itself a pardon.
More related reading
04 · Category
Prevalence and Usage30 stats
01
In 2022, approximately 52.5 million people aged 12 or older in the United States reported using cannabis in the past year, representing 18.7% of the population in that age group
02
A 2023 study found that 22.0% of U.S. adults aged 18-25 used cannabis in the past month, the highest rate among age groups
03
Globally, an estimated 219 million people used cannabis in 2022, making it the most widely used drug worldwide
04
In Canada, cannabis use among young adults aged 20-24 reached 39% in the past year following legalization in 2018
05
The 2021 European Drug Report indicated that 8% of young adults (15-34) in the EU had used cannabis in the past year
06
In Australia, lifetime cannabis use among people aged 14+ was 31.6% in 2022-2023
07
U.S. past-month cannabis use among adults rose from 7.5% in 2015 to 15.3% in 2021
08
In 2023, 48% of New Zealand adults reported lifetime cannabis use
09
Among U.S. high school students, 15.8% reported past-year cannabis use in 2023, down from previous years
10
In the UK, 16.7% of adults aged 16-59 used cannabis in the last year per 2022 Crime Survey
11
Mexico saw 5.4% past-month cannabis use among adults in 2022
12
In 2021, 29.6 million Americans aged 12+ used cannabis in the past 30 days
13
Brazil's 2019 survey showed 8.4% lifetime prevalence among those 12-65
14
South Africa's 2019 data indicated 15% past-year use among 15-64 year olds
15
In Japan, lifetime cannabis use is only 1.8% due to strict laws, per 2020 survey
16
Germany's 2021 data showed 7.7% past-year use among 18-64 year olds
17
In 2023, 42% of U.S. college students reported lifetime cannabis use
18
Israel's medical cannabis patient registry grew to 130,000 by 2023
19
Past-day cannabis use in U.S. adults tripled from 0.9% in 2015 to 2.8% in 2022
20
In Uruguay, post-legalization, 16% of adults used cannabis in past year by 2022
21
Chronic daily cannabis use in U.S. adults reached 10.3 million in 2021
22
In 2022, 61.9 million Americans aged 12+ used cannabis past year, up from 47 million in 2019
23
Past 30-day use among U.S. 12th graders dropped to 15.8% in 2023
24
In Europe, 22 million used cannabis past year in 2022
25
Daily or near-daily use in U.S. adults reached 6.5 million in 2022
26
Women’s past-year cannabis use increased 4.3% to 19.6% from 2019-2022
27
In 2023, 28 states plus DC had recreational sales
28
Black Americans past-year use at 19.5% matching whites in 2022
29
Edible cannabis use past year 4.5 million U.S. adults 2021
30
Concentrate/dabs use past year 11% among young adults 2023
Interpretation
Prevalence and Usage Interpretation
The world is lighting up more than a holiday fireworks display, with cannabis use now so widespread it's practically a global handshake, though the party favors—from gummies to dabs—and attendance rates vary dramatically by country, age, and law book.
05 · Category
Risks and Adverse Effects30 stats
01
Heavy cannabis use associated with 2.1-fold increased risk of schizophrenia in men
02
Daily cannabis use linked to 34% higher risk of heart attack per 2024 study
03
Adolescent cannabis use increases depression risk by 37% in adulthood
04
THC impairs driving, doubling crash risk equivalent to 0.08% BAC alcohol
05
Cannabis use disorder affects 22-30% of users, per NIDA
06
Vaping cannabis causes EVALI in 2,800 cases with 68 deaths by 2020
07
Prenatal cannabis exposure linked to 2.4x low birth weight risk
08
Chronic use reduces lung function by 8% in FEV1 measures
09
High-potency cannabis (>10% THC) raises psychosis risk 5-fold
10
Emergency room visits for cannabis rose 15% annually 2015-2020
11
Cannabis smoke contains 20x more ammonia than tobacco smoke
12
Youth users show 8 IQ point decline persisting to adulthood
13
Cannabinoid hyperemesis syndrome cases increased 25x since 2000s
14
Mixing cannabis with tobacco raises dependence risk by 40%
15
Acute cannabis use impairs memory consolidation by 50% for 24 hours
16
Long-term use linked to gum disease in 3x more users
17
Pediatric cannabis ingestions via edibles rose 1500% 2017-2021
18
High-THC strains cause paranoia in 28% of users
19
Cannabis withdrawal symptoms affect 47% of daily users
20
Regular use increases testicular cancer risk by 20%
21
Cannabis use during pregnancy linked to 50% preterm birth increase
22
Daily use raises stroke risk 25% in young adults
23
Impaired cognition lasts 28 days post-abstinence in heavy users
24
Edible overdoses cause hospitalization in 1/6 child cases
25
Chronic bronchitis 20% higher in smokers
26
Psychotic episodes 4x more likely with daily high-potency use
27
Motivation syndrome in 34% young users
28
Tar in cannabis smoke 4x higher than tobacco per gram
29
Bipolar disorder risk doubles with adolescent onset use
30
CUD treatment success only 12% without intervention
Interpretation
Risks and Adverse Effects Interpretation
The compiled statistics suggest that while cannabis may offer some a temporary escape, its heavy or chronic use systematically trades fleeting relief for a mounting ledger of mental, physical, and social debts that society and individuals are now being forced to pay, with interest.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Catherine Wu. (2026, February 13). Cannabis Statistics. Gitnux. https://gitnux.org/cannabis-statistics
MLA
Catherine Wu. "Cannabis Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cannabis-statistics.
Chicago
Catherine Wu. 2026. "Cannabis Statistics." Gitnux. https://gitnux.org/cannabis-statistics.
Sources & references
80 datasets cited across this report · attribution is report-level